Cite
HARVARD Citation
Siddiqi, O. et al. (2022). Diflunisal treatment is associated with improved survival for patients with early stage wild-type transthyretin (ATTR) amyloid cardiomyopathy: the Boston University Amyloidosis Center experience. Amyloid. pp. 71-78. [Online].